1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6D200DE8CD6DAC1850025875300361F35
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/D200DE8CD6DAC1850025875300361F35?OpenDocument
18
19OpenDocument
2018.97.14.91
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




» Products & Services » » Medical Affairs » Clinical Trials

Document Excerpt: Best Practices in the Management of Investigator Initiated Trials in CNS Therapeutic Area: Structure, Activities and Oversight

DB Image

Excerpt in Cart

ID: MD-793


Features:

7 Info Graphics

15 Data Graphics

160+ Metrics

10 Narratives


Pages/Slides: 4


Published: 2021


Delivery Format: Online PDF Document


 

License Options:


Download FREE Excerpt

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
To download this excerpt, click "Download Free Excerpt".

To return to the study abstract to purchase the full study -
click here

This excerpt includes research findings and metrics from document #5693 “Best Practices in the Management of Investigator Initiated Trials in CNS Therapeutic Area: Structure, Activities and Oversight”.

Industries Profiled:
Biotech; Diagnostic; Pharmaceutical; Health Care; Consumer Products; Biopharmaceutical; Clinical Research; Laboratories


Companies Profiled:
Allergan; Blue Earth Diagnostics; EMD Serono; Gedeon Richter ; Guerbet; Ipsen; Jazz Pharmaceuticals; Lundbeck; Merck; Novartis; Sage Therapeutics; Sanofi; Solidfarma

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.